Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|February 4, 2017
USP39 Deubiquitinase Is Essential for <i>KRAS</i> Oncogene-driven CancerJulia M Fraile, Eusebio Manchado, Amaia Lujambio, et al.
Nature|October 23, 2014
In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 systemDanilo Maddalo, Eusebio Manchado, Carla P Concepcion, et al.
Biochemistry|March 8, 2023
Design and Biochemical Characterization of Peptidic Inhibitors of the Myb/p300 InteractionMatthew Jones, Philipp Grosche, Andreas Floersheimer, et al.
Cell Death and Differentiation|December 13, 2017
Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancerMónica Álvarez-Fernández, María Sanz-Flores, Belén Sanz-Castillo, et al.
Nature Biotechnology|May 2, 2017
Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancerKevin P O'Rourke, Evangelia Loizou, Geulah Livshits, et al.
Nature|June 25, 2016
A combinatorial strategy for treating KRAS-mutant lung cancerEusebio Manchado, Susann Weissmueller, John P Morris, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 8, 2021
Promoter-Driven Overexpression in Chromobacterium vaccinii Facilitates Access to FR900359 and Yields Novel Low Abundance AnalogsDominik Pistorius, Kathrin Buntin, Eric Weber, et al.
Molecular Cancer Therapeutics|May 10, 2019
SHP2 Inhibition Overcomes RTK-Mediated Pathway Reactivation in KRAS-Mutant Tumors Treated with MEK InhibitorsHengyu Lu, Chen Liu, Roberto Velazquez, et al.
Cancer Discovery|November 6, 2023
Alveolar Differentiation Drives Resistance to KRAS Inhibition in Lung AdenocarcinomaZhuxuan Li, Xueqian Zhuang, Chun-Hao Pan, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Alveolar differentiation drives resistance to KRAS inhibition in lung adenocarcinomaZhuxuan Li, Xueqian Zhuang, Chun-Hao Pan, et al.
Pageof 3